Author: Mark DeFrance

Mark DeFrance is a senior research analyst at Tech Insider, focusing on the enterprise software sector. Prior to joining TI, Mark covered enterprise software for First Albany, and prior to that he worked in equity research at B.T. Alex Brown and Bankers Trust. Mark has written software applications in various programming languages including BASIC, Pascal, and COBOL. He has also been recognized in The Wall Street Journal's "Best on the Street" survey and was recognized by Forbes Magazine as the No. 1 sell-side stock picker in the software industry for a five-year period, with returns of 115% versus 26% for the software industry.
Finance

Services Sector New Lows: Gordmans Stores (NASDAQ:GMAN), NewLead (NASDAQ:NEWL), C.H. Robinson Worldwide (NASDAQ:CHRW), The Wet Seal (NASDAQ:WTSL)

Gordmans Stores, Inc. (NASDAQ:GMAN) will open its third Idaho store 9 a.m. Thursday at Parkcenter Boulevard and Apple Street. The company has existing stores in Nampa and Meridian.Gordmans Stores, Inc. (NASDAQ:GMAN) stock performance was -0.83% in last session and finished the day at $5.97. Traded volume was 63,628 million shares in the last session and the average volume of the stock remained 79.81 million shares. … Continue reading Services Sector New Lows: Gordmans Stores (NASDAQ:GMAN), NewLead (NASDAQ:NEWL), C.H. Robinson Worldwide (NASDAQ:CHRW), The Wet Seal (NASDAQ:WTSL)

Mark DeFrance
Finance

Biotech Gainers: Inovio Pharmaceuticals Inc (NYSEMKT:INO), Galena Biopharma (NASDAQ:GALE), CEL-SCI Corporation (NYSEMKT:CVM), Synthetic Biologics (NYSEMKT:SYN)

Inovio Pharmaceuticals Inc (NYSEMKT:INO)’s shares climbed 4.96% to $3.60. The company on Mar. 17 reported financial results for the fourth quarter and year ended Dec. 31, 2013. Total revenue was $1.7 million and $13.5 million for the quarter and year ended December 31, 2013, as compared to $1.1 million and $4.1 million for the same periods in 2012. Inovio Pharmaceuticals Inc (NYSEMKT:INO) stock performance was … Continue reading Biotech Gainers: Inovio Pharmaceuticals Inc (NYSEMKT:INO), Galena Biopharma (NASDAQ:GALE), CEL-SCI Corporation (NYSEMKT:CVM), Synthetic Biologics (NYSEMKT:SYN)

Mark DeFrance
Finance

Services Sector Losers: Lentuo International (NYSE:LAS), Trans World Entertainment (NASDAQ:TWMC), Hudson Global (NASDAQ:HSON), Nevada Gold & Casinos (NYSEMKT:UWN)

Lentuo International Inc. (NYSE:LAS) a leading non-state-owned automobile retailer headquartered in Beijing, today announced that it has signed a strategic agreement with China Orient Tiantong Capital Management Ltd. a subsidiary of China Orient Asset Management Corporation, a major state-owned financial asset management company. Lentuo International Inc. (ADR) (NYSE:LAS) stock performance was -5.74% in last session and finished the day at $4.43. Traded volume was 29,350.00 … Continue reading Services Sector Losers: Lentuo International (NYSE:LAS), Trans World Entertainment (NASDAQ:TWMC), Hudson Global (NASDAQ:HSON), Nevada Gold & Casinos (NYSEMKT:UWN)

Mark DeFrance
Finance

NASDAQ Active Runners: Facebook Inc (NASDAQ:FB), Intel Corporation (NASDAQ:INTC), Plug Power Inc (NASDAQ:PLUG), FuelCell Energy Inc (NASDAQ:FCEL)

Ever since highly-successful messaging startup WhatsApp was bought out by Facebook Inc (NASDAQ:FB) for $19 billion a few weeks ago, WhatsApp users have been asking for reassurance regarding their privacy after the deal with the social media giant closes. Facebook Inc (NASDAQ:FB) stock performance was 1.51% in last session and finished the day at $68.74. Traded volume was 52,084,432 million shares in the last session … Continue reading NASDAQ Active Runners: Facebook Inc (NASDAQ:FB), Intel Corporation (NASDAQ:INTC), Plug Power Inc (NASDAQ:PLUG), FuelCell Energy Inc (NASDAQ:FCEL)

Mark DeFrance
BioTech

Biotech Active Stocks: Gilead Sciences (NASDAQ:GILD), Ariad Pharmaceuticals (NASDAQ:ARIA), Inovio Pharmaceuticals Inc (NYSEMKT:INO), Geron Corporation (NASDAQ:GERN)

The iShares Biotechnology Indexhas fallen 2.46% in the last month of trading, and biotech stalwarts Celgene (NASDAQ:CELG) and Gilead Sciences (NASDAQ:GILD ) are both down over 8%. What’s most surprising is that Celgene and Gilead are expected to have strong years in terms of earnings and the development of their respective clinical pipelines. Gilead Sciences, Inc. (NASDAQ:GILD) stock performance was 0.53% in last session and … Continue reading Biotech Active Stocks: Gilead Sciences (NASDAQ:GILD), Ariad Pharmaceuticals (NASDAQ:ARIA), Inovio Pharmaceuticals Inc (NYSEMKT:INO), Geron Corporation (NASDAQ:GERN)

Mark DeFrance
Analyst Actions

Stocks Moving After-Hours: Regeneron Pharmaceuticals Inc (NASDAQ:REGN), Kinder Morgan Management (NYSE:KMR), FutureFuel (NYSE:FF)

Citigroup upgraded it rating on Regeneron Pharmaceuticals Inc (NASDAQ:REGN) to Buy from Neutral after its survey of retinal surgeons indicated the company’s Eylea drug will beat estimates over the near and long term. Citi also believes Regeneron’s pipeline is not adequately reflected in the current share price. The firm raised its price target for the stock to $390 from $342. Shares of Regeneron (REGN) closed … Continue reading Stocks Moving After-Hours: Regeneron Pharmaceuticals Inc (NASDAQ:REGN), Kinder Morgan Management (NYSE:KMR), FutureFuel (NYSE:FF)

Mark DeFrance